Immunogenicity 15679
Sample ID
None
Response
Positive
Tumor Type
Melanoma
Gene Symbol
CTNNB1
Transcript ID
None
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (781 aa)
MATQA
1
DLMEL
6
DMAME
11
PDRKA
16
AVSHW
21
QQQSY
26
LDSGI
31
HSGAT
36
TTAPS
41
LSGKG
46
NPEEE
51
DVDTS
56
QVLYE
61
WEQGF
66
SQSFT
71
QEQVA
76
DIDGQ
81
YAMTR
86
AQRVR
91
AAMFP
96
ETLDE
101
GMQIP
106
STQFD
111
AAHPT
116
NVQRL
121
AEPSQ
126
MLKHA
131
VVNLI
136
NYQDD
141
AELAT
146
RAIPE
151
LTKLL
156
NDEDQ
161
VVVNK
166
AAVMV
171
HQLSK
176
KEASR
181
HAIMR
186
SPQMV
191
SAIVR
196
TMQNT
201
NDVET
206
ARCTA
211
GTLHN
216
LSHHR
221
EGLLA
226
IFKSG
231
GIPAL
236
VKMLG
241
SPVDS
246
VLFYA
251
ITTLH
256
NLLLH
261
QEGAK
266
MAVRL
271
AGGLQ
276
KMVAL
281
LNKTN
286
VKFLA
291
ITTDC
296
LQILA
301
YGNQE
306
SKLII
311
LASGG
316
PQALV
321
NIMRT
326
YTYEK
331
LLWTT
336
SRVLK
341
VLSVC
346
SSNKP
351
AIVEA
356
GGMQA
361
LGLHL
366
TDPSQ
371
RLVQN
376
CLWTL
381
RNLSD
386
AATKQ
391
EGMEG
396
LLGTL
401
VQLLG
406
SDDIN
411
VVTCA
416
AGILS
421
NLTCN
426
NYKNK
431
MMVCQ
436
VGGIE
441
ALVRT
446
VLRAG
451
DREDI
456
TEPAI
461
CALRH
466
LTSRH
471
QEAEM
476
AQNAV
481
RLHYG
486
LPVVV
491
KLLHP
496
PSHWP
501
LIKAT
506
VGLIR
511
NLALC
516
PANHA
521
PLREQ
526
GAIPR
531
LVQLL
536
VRAHQ
541
DTQRR
546
TSMGG
551
TQQQF
556
VEGVR
561
MEEIV
566
EGCTG
571
ALHIL
576
ARDVH
581
NRIVI
586
RGLNT
591
IPLFV
596
QLLYS
601
PIENI
606
QRVAA
611
GVLCE
616
LAQDK
621
EAAEA
626
IEAEG
631
ATAPL
636
TELLH
641
SRNEG
646
VATYA
651
AAVLF
656
RMSED
661
KPQDY
666
KKRLS
671
VELTS
676
SLFRT
681
EPMAW
686
NETAD
691
LGLDI
696
GAQGE
701
PLGYR
706
QDDPS
711
YRSFH
716
SGGYG
721
QDALG
726
MDPMM
731
EHEMG
736
GHHPG
741
ADYPV
746
DGLPD
751
LGHAQ
756
DLMDG
761
LPPGD
766
SNQLA
771
WFDTD
776
L
781
Mutation Information
DNA mutation:
None
Peptide Range:
29 ~ 37
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"SYLDSGIHS
||||||||.
Mutant:
SYLDSGIHF"
J Exp Med, 1996
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytesGene Name (from Reference) CTNNB1
Checkpoint
Blockade
None
ACT
N
Vaccination
N
Curative
Effect
None
minimal_peptide
Y
Antigen
Type
None
T-cell
Source
None
APC
Type
None
Assay
None